Bochenek, Wieslaw

Efficacy of linaclotide in reducing abdominal symptoms of bloating, discomfort, and pain: A phase 3B trial using a novel abdominal scoring system

Chang, L., Lacy, B. E., Moshiree, B., Kassebaum, A., Abel, J. L., Hanlon, J., Bartolini, W., Boinpally, R., Bochenek, W., Fox, S. M., et al. (2021) · American Journal of Gastroenterology

Gastrointestinal motility and disordersInflammatory Bowel Disease

Cited by 56

Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

Chey, W. D., Sayuk, G. S., Bartolini, W., Reasner, D. S., Fox, S. M., Bochenek, W., Boinpally, R., Shea, E., Tripp, K., & Borgstein, N. (2021) · American Journal of Gastroenterology

Gastrointestinal motility and disordersInflammatory Bowel Disease

Cited by 41

Targeted Delivery of Linaclotide to Specific Areas of The Intestine Affects Clinical Efficacy in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Chey, W. D., Chamberlin, P., Bochenek, W., Tripp, K., Higgins, C. S., Omniewski, N., Fox, S. M., Hall, M., Hashash, A., Miller, M., et al. (2017) · Gastroenterology

Gastrointestinal motility and disordersAdvanced Drug Delivery Systems

Cited by 6